Need help?

In Stock

Kaplan And Sadock’s Synopsis Of Psychiatry 11th Edition Test Bank

  • Publisher ‏ : ‎ LWW; Eleventh edition
  • ISBN-10 ‏ : ‎ 1609139712
  • ISBN-13 ‏ : ‎ 978-1609139711



Kaplan And Sadock’s Synopsis Of Psychiatry 11th Edition Test Bank


Chapter 1: Neural Sciences
1.1: Introduction
1.2: Functional Neuroanatomy
1.3: Neural Development and Neurogenesis
1.4: Neurophysiology and Neurochemistry
1.5: Psychneuroendocrinology
1.6: Immune System and Central Nervous System Interactions
1.7: Neurogenetics
1.8: Applied Electrophysiology
1.9: Chronobiology
Chapter 2: Contributions of the Psychosocial Sciences
2.1: Jean Piaget and Cognitive Development
2.2: Attachment Theory
2.3: Learning Theory
2.4: Biology of Memory
2.5: Normality and Mental Health
Chapter 3: Contributions of the Sociocultural Sciences
3.1: Sociobiology and Ethology
3.2: Transcultural Psychiatry
3.3: Culture-Bound Syndromes
Chapter 4: Theories of Personality and Psychopathology
4.1: Sigmund Freud: Founder of Classic Psychoanalysis
4.2: Erik Erikson
4.3: Other Psychodynamic Schools
4.4: Positive Psychology
Chapter 5: Examination and Diagnosis of the Psychiatric Patient
5.1: Psychiatric Interview, History, and Mental Status Examination
5.2: The Psychiatric Report and Medical Record
5.3: Psychiatric Rating Scales
5.4: Clinical Neuropsychology and Intellectual Assessment of Adults
5.5: Personality Assessment: Adults and Children
5.6: Neuropsychological and Cognitive Assessment of Children
5.7: Medical Assessment and Laboratory Testing in Psychiatry
5.8: Neuroimaging
5.9: Physical Examination of the Psychiatric Patient
Chapter 6: Classification in Psychiatry
Chapter 7: Schizophrenia Spectrum and Other Psychotic Disorders
7.1: Schizophrenia
7.2: Schizoaffective Disorder
7.3: Schizophreniform Disorder
7.4: Delusional Disorder and Shared Psychotic Disorder
7.5: Brief Psychotic Disorder, Other Psychotic Disorders, and Catatonia
Chapter 8: Mood Disorders
8.1: Depression and Bipolar Disorder
8.2: Dysthymia and Cyclothymia
Chapter 9: Anxiety Disorders
9.1: Overview
9.2: Panic Disorder
9.3: Agoraphobia
9.4: Specific Phobia
9.5: Social Anxiety Disorder (Social Phobia)
9.6: Generalized Anxiety Disorder
9.7: Other Anxiety Disorders
Chapter 10: Obsessive-Compulsive and Related Disorders
10.1: Obsessive-Compulsive Disorder
10.2: Body Dysmorphic Disorder
10.3: Hoarding Disorder
10.4: Hair-Pulling Disorder (Trichotillomania)
10.5: Excoriation (Skin Picking) Disorder
Chapter 11: Trauma- and Stressor-Related Disorders
11.1: Posttraumatic Stress Disorder and Acute Stress Disorder
11.2: Adjustment Disorders
Chapter 12: Dissociative Disorders
Chapter 13: Psychosomatic Medicine
13.1: Introduction and Overview
13.2 Somatic Symptom Disorder
13.3: Illness Anxiety Disorder
13.4: Functional Neurological Symptom Disorder (Conversion Disorder)
13.5: Psychological Factors Affecting Other Medical Conditions
13.6: Factitious Disorder
13.7: Pain Disorder
13.8: Consultation-Liaison Psychiatry
Chapter 14: Chronic Fatigue Syndrome and Fibromyalgia
Chapter 15: Feeding and Eating Disorders
15.1: Anorexia Nervosa
15.2: Bulimia Nervosa
15.3: Binge Eating Disorder and Other Eating Disorders
15.4: Obesity and the Metabolic Syndrome
Chapter 16: Normal Sleep and Sleep-Wake Disorders
16.1: Normal Sleep
16.2: Sleep-Wake Disorders
Chapter 17: Normal Sexuality and Sexual Dysfunctions
17.1: Normal Sexuality
17.2: Sexual Dysfunctions
17.3: Paraphilic Disorders
Chapter 18: Gender Dysphoria
Chapter 19: Disruptive, Impulse Control, and Conduct Disorders
Chapter 20: Substance Use and Addictive Disorders
20.1: Introduction and Overview
20.2: Alcohol-Related Disorders
20.3: Caffeine-Related Disorders
20.4: Cannabis-Related Disorders
20.5: Hallucinogen-Related Disorders
20.6: Inhalant-Related Disorders
20.7: Opioid-Related Disorders
20.8: Sedative-, Hypnotic-, or Anxiolytic-Related Disorders
20.9: Stimulant-Related Disorders
20.10: Tobacco-Related Disorders
20.11: Anabolic-Androgenic Steroid Abuse
20.12: Other Substance Use and Addictive Disorders
20.13: Gambling Disorder
Chapter 21: Neurocognitive Disorders
21.1: Introduction and Overview
21.2: Delirium
21.3: Dementia (Major Neurocognitive Disorder)
21.4: Major or Minor Neurocognitive Disorder Due to Another Medical Condition (Amnestic Disorders)
21.5: Neurocognitive and Other Mental Disorders Due to a General Medical Condition
21.6: Mild Cognitive Impairment
Chapter 22: Personality Disorders
Chapter 23: Emergency Psychiatric Medicine
23.1: Suicide
23.2: Psychiatric Emergencies in Adults
23.3: Psychiatric Emergencies in Children
Chapter 24: Complementary and Alternative Medicine in Psychiatry
Chapter 25: Other Conditions that May be a Focus of Clinical Attention
Chapter 26: Physical and Sexual Abuse of Adults
Chapter 27: Psychiatry and Reproductive Medicine
Chapter 28: Psychotherapies
28.1: Psychoanalysis and Psychoanalytic Psychotherapy
28.2: Brief Psychodynamic Psychotherapy
28.3: Group Psychotherapy, Combined Individual and Group Psychotherapy, and Psychodrama
28.4: Family Therapy and Couples Therapy
28.5: Dialectical Behavior Therapy
28.6: Biofeedback
28.7: Cognitive Therapy
28.8 Behavior Therapy
28.9: Hypnosis
28.10: Interpersonal Therapy
28.11: Narrative Psychotherapy
28.12: Psychiatric Rehabilitation
28.13: Combined Psychotherapy and Pharmacotherapy
28.14: Genetic Counseling
28.15: Mentalization-Based Therapy and Mindfulness
Chapter 29: Psychopharmacological Treatment
29.1: General Principles of Psychopharmacology
29.2: Medication-Induced Movement Disorders
29.3: α2-Adrenergic Receptor Antagonists, α1-Adrenergic Receptor Antagonists: Clonidine, Guanfacine, Minipress, and Yohimbine
29.4: β-Adrenergic Receptor Antagonists
29.5: Anticholinergic Agents
29.6: Anticonvulsants
29.7: Antihistamines
29.8: Barbiturates and Similarly Acting Substances
29.9: Benzodiazepines and Drugs Acting on GABA Receptors
29.10: Bupropion
29.11: Buspirone
29.12: Calcium Channel Blockers
29.13: Carbamazepine and Oxcarbazepine
29.14: Cholinesterase Inhibitors and Memantine
29.15: Disulfiram and Acamprosate
29.16: Dopamine Receptor Agonists and Precursors
29.17: Dopamine Receptor Antagonists (First-Generation Antipsychotics)
29.18: Lamotrigine
29.19: Lithium
29.20: Melatonin Agonists: Ramelton and Melatonin
29.21: Mirtazepine
29.22: Monoamine Oxidase Inhibitors
29.23: Nefazodone and Trazodone
29.24: Opioid Receptor Agonists
29.25: Opioid Receptor Antagonists: Naltrexone, Nalmefene, and Naloxone
29.26: Phosphodiesterase-5 Inhibiors
29.27: Selective Serotonin-Norepinephrine Reuptake Inhibitors
29.28: Selective Serotonin Reuptake Inhibitors
29.29: Serotonin-Dopamine Antagonists and Similarly Acting Drugs (Second-Generation or Atypical Antipsychotics)
29.30: Stimulant Drugs and Atomoxetine
29.31: Thyroid Hormones
29.32: Tricyclics and Tetracyclics
29.33: Valproate
29.34: Nutritional Supplements and Medical Foods
29.35: Weight Loss drugs
Chapter 30: Brain Stimulation Methods
30.1: Electroconvulsive Therapy
30.2: Other Brain Stimulation Methods
30.3: Neurosurgical Treatments and Deep Brain Stimulation
Chapter 31: Child Psychiatry
31.1: Introduction: Infant, Child, and Adolescent Development
31.2: Assessment, Examination, and Psychological Testing
31.3: Intellectual Disability
31.4: Communication Disorders
31.4a: Language Disorder
31.4b: Speech Sound Disorder
31.4c: Child-Onset Fluency Disorder (Stuttering)
31.4d: Social (Pragmatic) Communication Disorder
31.4e: Unspecified Communication Disorder
31.5: Autism Spectrum Disorder
31.6: Attention Deficit Disorders
31.7: Specific Learning Disorder
31.8: Motor Disorders
31.8a: Developmental Coordination Disorder
31.8b: Stereotypic Movement Disorder
31.8c: Tourette’s Disorder
31.8d: Persistent (Chronic) Motor or Vocal Tic Disorder
31.9: Feeding and Eating Disorders of Infancy or Early Childhood
31.9a: Pica
31.9b: Rumination Disorder
31.9c: Avoidant/Restrictive Food Intake Disorder (ARFID)
31.10: Elimination Disorders
31.10a: Encopresis
31.10b: Enuresis
31.11: Trauma- and Stressor-Related Disorders in Children
31.11a: Reactive Attachment Disorder and Disinhibited Social Engagement Disorder
31.11b: Posttraumatic Stress Disorder of Infancy, Childhood, and Adolescence
31.12: Mood Disorders and Suicide in Children and Adolescents
31.12a: Depressive Disorders and Suicide in Children and Adolescents
31.12b: Early-Onset Bipolar Disorder
31.12c: Disruptive Mood Dyregulation Disorder
31.12d: Oppositional Defiant Disorder
31.12e: Conduct Disorder
31.13: Anxiety Disorders of Infancy, Childhood, Adolescence
31.13a: Separation Anxiety Disorder, Generalized Anxiety Disorder, and Social Anxiety Disorder (Social Phobia)
31.13b: Selective Mutism
31.14: Obsessive-Compulsive Disorder in Childhood and Adolescence
31.15: Early-Onset Schizophrenia
31.16: Adolescent Substance Abuse
31.17: Child Psychiatry: Other Conditions
31.17a: Attenuated Psychosis Syndrome
31.17b: Academic Problem
31.17c: Identity Problem
31.18: Psychiatric Treatment of Children and Adolescents
31.18a: Individual Psychotherapy
31.18b: Group Psychotherapy
31.18c: Residential, Day, and Hospital Treatment
31.18d: Pharmacotherapy
31.18e: Psychiatric Treatment of Adolescents
31.19: Child Psychiatry: Special Areas of Interest
31.19a: Forensic Issues in Child Psychiatry
31.19b: Adoption and Foster Care
31.19c: Child Maltreatment and Abuse
31.19d: Impact of Terrorism on Children
Chapter 32: Adulthood
Chapter 33: Geriatric Psychiatry
Chapter 34: End of Life Issues
34.1: Death, Dying, and Bereavement
34.2: Palliative Care
34.3: Euthanasia and Physician-Assisted Suicide
Chapter 35: Public Psychiatry
Chapter 36: Forensic Psychiatry and Ethics in Psychiatry
36.1: Forensic Psychiatry
36.2: Ethics in Psychiatry
Chapter 37: World Aspects of Psychiatry


There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *



Back to Top
Product has been added to your cart